This Page Intentionally Left Blank - Int Medical

76 Nonstandard medication delivery
36. Kotwal RS, O’Connor KC, Johnson TR, et al. A novel pain management
strategy for combat casualty care. Ann Emerg Med. 2004;44(2):121–127.
37. Mahar PJ, Rana JA, Kennedy CS, et al. A randomized clinical trial of oral
transmucosal fentanyl citrate versus intravenous morphine sulfate for initial
control of pain in children with extremity injuries. Pediatr Emerg Care.
2007;23(8):544–548.
38. Griessinger N, Sittl R, Likar R. Transdermal buprenorphine in clinical practice –
a post-marketing surveillance study in 13 179 patients. Curr Med Res Opin.
2005;21(8):1147–1156.
39. Koo PJ. Postoperative pain management with a patient-controlled transdermal
delivery system for fentanyl. Am J Health Syst Pharm. 1 2005;62(11):1171–
1176.
40. Hartrick CT, Bourne MH, Gargiulo K, et al. Fentanyl iontophoretic transdermal
system for acute-pain management after orthopedic surgery: a comparative
study with morphine intravenous patient-controlled analgesia. Reg
Anesth Pain Med. 2006;31(6):546–554.
41. Mayes S, Ferrone M. Fentanyl HCl patient-controlled iontophoretic transdermal
system for the management of acute postoperative pain. Ann
Pharmacother. 2006;40(12):2178–2186.
42. Sinatra R. The fentanyl HCl patient-controlled transdermal system (PCTS): an
alternative to intravenous patient-controlled analgesia in the postoperative
setting. Clin Pharmacokinet. 2005;44(Suppl 1):1–6.